Cynvenio is the pioneer in LiquidBiopsy® technology for the genomic analysis of tumor cells from whole blood in support of cancer precision medicine strategies.

 
ClearID™ + NK Vue™ Testing Complementary tests that support clinical decisions when monitoring patients before, during and after cancer treatment. Learn More →

ClearID + NK Vue Testing

Complementary tests that support clinical decisions when monitoring patients before, during and after cancer treatment.

Learn More →

LiquidBiopsy® Testing A risk-free, painless method to dynamically sample study participants and sequentially measure response to treatment. Learn More →

LiquidBiopsy® Testing

A risk-free, painless method to dynamically sample study participants and sequentially measure response to treatment.

Learn More →

LiquidBiopsy® Platform An automated rare cell isolation and staining front-end for all types of molecular characterization, especially sequencing. Learn More →

LiquidBiopsy® Platform

An automated rare cell isolation and staining front-end for all types of molecular characterization, especially sequencing.

Learn More →